Evidence map›Paper›PMID 30455225›Full record

ArticleCold Spring Harbor molecular case studies2018

A case of

Christopher J Forlenza, Yanming Zhang, JinJuan Yao, Ryma Benayed, Peter Steinherz, Kavitha Ramaswamy, Rachel Kessel, Mikhail Roshal, Neerav Shukla

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Structure and function of Septin 9 and its role in human malignant tumors.World journal of gastrointestinal oncology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Christopher J ForlenzaDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Yanming ZhangDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
JinJuan YaoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Ryma BenayedDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Peter SteinherzDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Kavitha RamaswamyDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Rachel KesselDivision of Hematology/Oncology and Stem Cell Transplantation, Cohen Children's Medical Center of New York, New Hyde Park, New York 11042, USA.
Mikhail RoshalDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Neerav ShuklaDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Memorial Sloan Kettering Cancer Center · USCohen Children's Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Acute megakaryoblastic leukemia (AMKL) constitutes ∼5%-15% of cases of non-Down syndrome AML in children, and in the majority of cases, chimeric oncogenes resulting from recurrent gene rearrangements are identified. Based on these rearrangements, several molecular subsets have been characterized providing important prognostic information. One such subset includes a group of patients with translocations involving the

Indexed as

Bone Marrow TransplantationChild, PreschoolFemaleGene RearrangementHistone-Lysine N-MethyltransferaseHumansLeukemia, Megakaryoblastic, AcuteMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionPrognosisSeptinsTranslocation, GeneticHistone-Lysine N-MethyltransferaseKMT2A protein, humanMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionSEPTIN9 protein, humanSeptinsacute megakaryocytic leukemiaacute myeloid leukemialeukemia

Identifiers

PMID30455225
PMCPMC6318764
OpenAlexW2900705336

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.